The Relationship of Hyperferritinemia to Metabolism and Chronic Complications in Type 2 Diabetes

References

• Recalcati S, Gammella E, Buratti P, et al. Molecular regulation of cellular iron balance. IUBMB Life. 2017;69(6):389–398. doi:10.1002/iub.1628
   PubMed Web of Science ®Google Scholar
• Brissot P, Ropert M, Le Lan C, et al. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Act. 2012;1820(3):403–410. doi:10.1016/j.bbagen.2011.07.014
   PubMed Web of Science ®Google Scholar
• Podmore C, Meidtner K, Schulze MB, et al. Association of multiple biomarkers of iron metabolism and type 2 diabetes: the EPIC-interact study. Diabetes Care. 2016;39(4):572–581. doi:10.2337/dc15-0257
   PubMed Web of Science ®Google Scholar
• Altamura S, Kopf S, Schmidt J, et al. Uncoupled iron homeostasis in type 2 diabetes mellitus. J Mol Med. 2017;95(12):1387–1398. doi:10.1007/s00109-017-1596-3
   Web of Science ®Google Scholar
• Zhang C, Zhang F. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell. 2015;6(2):88–100. doi:10.1007/s13238-014-0119-z
   PubMed Web of Science ®Google Scholar
• Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics. 2009;8(2). doi:10.1186/1755-8794-2-2
   Web of Science ®Google Scholar
• Kobayashi M, Suhara T, Baba Y, et al. Pathological roles of iron in cardiovascular disease. Curr Drug Targets. 2018;19(9):1068–1076. doi:10.2174/1389450119666180605112235
   PubMed Web of Science ®Google Scholar
• Recalcati S, Invernizzi P, Arosio P, et al. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun. 2008;30(1–2):84–89. doi:10.1016/j.jaut.2007.11.003
   PubMed Web of Science ®Google Scholar
• Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401–409. doi:10.1093/intimm/dxx031
   PubMed Web of Science ®Google Scholar
• Suárez-Ortegón MF, McLachlan S, Price AH, et al. Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinally. Atherosclerosis. 2018;272:193–199. doi:10.1016/j.atherosclerosis.2018.03.028
   Web of Science ®Google Scholar
• Hermans MP, Ahn SA, Amoussou-Guenou KD, et al. Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes? Diabet Med. 2010;27:417–422. doi:10.1111/j.1464-5491.2010.02979.x
   Web of Science ®Google Scholar
• Mokhtari H, Bagherib B, Rasoulia M. Iron hypothesis and coronary artery disease in geriatric patients. Arch Physiol Biochem. 2020;126(1):1,17–22. doi:10.1080/13813455.2018.1486429
   Web of Science ®Google Scholar
• Smotra S, Kudyar RP. Relationship between serum ferritin and type-2 diabetes mellitus. JK Sci. 2008;10(4):170–174.
   Google Scholar
• Hong S, San WY, Yu SZ. National Clinical Laboratory Operating Procedures. Beijing, China: People’s Health Publishing House; 2015:121.
   Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Khan A, Khan WM, Ayub M, et al. Ferritin is a marker of inflammation rather than iron deficiency in overweight and obese People. J Obes. 2016;2016:1937320. doi:10.1155/2016/1937320
   Google Scholar
• Musina N, Saprina VT, Prokhorenko ST, et al. Correlations between iron metabolism parameters, inflammatory markers and lipid profile indicators in patients with type 1 and type 2 diabetes mellitus. J Pers Med. 2020;10(3):70. doi:10.3390/jpm10030070
   Web of Science ®Google Scholar
• Chen L, Li Y, Zhang F, et al. Association of serum ferritin levels with metabolic syndrome and insulin resistance in a Chinese population. J Diabetes Complications. 2017;31(2):364–368. doi:10.1016/j.jdiacomp.2016.06.018
   PubMed Web of Science ®Google Scholar
• Tang Q, Liu Z, Tang Y, et al. High serum ferritin level is an independent risk factor for metabolic syndrome in a Chinese male cohort population. Diabetol Metab Syndr. 2015;7(1):11. doi:10.1186/s13098-015-0004-9
   Web of Science ®Google Scholar
• Tofano RJ, Pescinni-Salzedas LM, Chagas EFB, et al. Association of metabolic syndrome and hyperferritinemia in patients at cardiovascular risk. Diabetes Metab Syndr Obes. 2020;13:3239–3248. doi:10.2147/DMSO.S271050
   PubMed Web of Science ®Google Scholar
• Rametta R, Fracanzani AL, Fargion S, et al. Dysmetabolic hyperferritinemia and dysmetabolic iron overload syndrome (DIOS): two related conditions or different entities? Curr Pharm Des. 2020;26(10):1025–1035. doi:10.2174/1381612826666200131103018
   PubMed Web of Science ®Google Scholar
• Datz C, Müller E, Aigner E. Iron overload and non-alcoholic fatty liver disease. Minerva Endocrinol. 2017;42(2):173–183. doi:10.23736/S0391-1977.16.02565-7
   PubMed Web of Science ®Google Scholar
• Buzzetti E, Petta S, Manuguerra R, et al. Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease. Liver Int. 2019;39(7):1325–1334. doi:10.1111/liv.14096
   Web of Science ®Google Scholar
• Ruddell RG, Hoang-le D, Barwood JM, et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/ nuclear factor kappa B-regulated signaling in rat hepatic stellate cells. Hepatology. 2009;49(3):887. doi:10.1002/hep.22716
   PubMed Web of Science ®Google Scholar
• Yang Z, Wu J, Li X, et al. Association between dietary iron intake and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study. Medicine. 2019;98(43):e17613. doi:10.1097/MD.0000000000017613
   Web of Science ®Google Scholar
• Qi L, van Dam RM, Rexrode K, et al. Heme iron from diet as a risk factor for coronary heart disease in women with type 2 diabetes. Diabetes Care. 2007;30(1):101–106. doi:10.2337/dc06-1686
   PubMed Web of Science ®Google Scholar
• Misra R, Balagopal P, Raj S, et al. Red meat consumption (Heme Iron Intake) and risk for diabetes and comorbidities? Curr Diab Rep. 2018;18(11):100. doi:10.1007/s11892-018-1071-8
   PubMed Web of Science ®Google Scholar
• Hou Y, Zhang S, Wang L, et al. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene. 2012;511(2):398–403. doi:10.1016/j.gene.2012.09.060
   PubMed Web of Science ®Google Scholar
• Huang LN, Wang HJ, Wang ZH, et al. Association of red meat usual intake with serum ferritin and the risk of metabolic syndrome in Chinese adults: a longitudinal study from the China Health and Nutrition Survey. Biomed Environ Sci. 2020;33(1):19–29. doi:10.3967/bes2020.003
   Web of Science ®Google Scholar
• Hsu YH, Huang MC, Chang HY, et al. Association between serum ferritin and microalbuminuria in Type 2 diabetes in Taiwan. Diabet Med. 2013;30(11):1367–1373. doi:10.1111/dme.12257
   Web of Science ®Google Scholar
• Wu YH, Wang SY, Li MX, et al. Serum ferritin independently predicts the incidence of chronic kidney disease in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2020;13:99–105. doi:10.2147/DMSO.S228335
   PubMed Web of Science ®Google Scholar
• Chaudhary K, Promsote W, Ananth S, et al. Iron overload accelerates the progression of diabetic retinopathy in association with increased retinal renin expression. Sci Rep. 2018;8(1):1–12. doi:10.1038/s41598-018-21276-2
   PubMed Web of Science ®Google Scholar
• Chaudhary K, Chilakala A, Ananth S, et al. Renal iron accelerates the progression of diabetic nephropathy in the HFE gene knockout mouse model of iron overload. Am J Physiol Renal Physiol. 2019;317(2):512–517. doi:10.1152/ajprenal.00184.2019
   PubMed Web of Science ®Google Scholar
• You SA, Archacki SR, Angheloiu G, et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics. 2003;13(1):25–30. doi:10.1152/physiolgenomics.00124.2002
   PubMed Web of Science ®Google Scholar
• Gill D, Del Greco MF, Walker AP, et al. The effect of iron status on risk of coronary artery disease: a Mendelian randomization study-brief report. Arterioscler Thromb Vasc Biol. 2017;37(9):1788–1792. doi:10.1161/ATVBAHA.117.309757
   Web of Science ®Google Scholar
• Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86(3):803–811. doi:10.1161/01.cir.86.3.803
   PubMed Web of Science ®Google Scholar
• Xu S. Iron and atherosclerosis: the link revisited. Trends Mol Med. 2019;25(8):659–661. doi:10.1016/j.molmed.2019.05.012
   PubMed Web of Science ®Google Scholar